Identification of Novel Targets for Treatment of Dilated Cardiomyopathy Based on the Ferroptosis and Immune Heterogeneity

References

• Weintraub RG, Semsarian C, Macdonald P. Dilated cardiomyopathy. Lancet. 2017;390(10092):400–414.
   PubMed Web of Science ®Google Scholar
• Feldtmann R, Kümmel A, Chamling B, et al. Myeloid differentiation factor-2 activates monocytes in patients with dilated cardiomyopathy. Immunology. 2022;167(1):40–53.
   PubMed Web of Science ®Google Scholar
• Sun X, Duan J, Gong C, et al. Colchicine ameliorates dilated cardiomyopathy via SIRT2-mediated suppression of NLRP3 inflammasome activation. J Am Heart Assoc. 2022;11(13):e025266.
   PubMed Web of Science ®Google Scholar
• Dávila-Román VG, Vedala G, Herrero P, et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2002;40(2):271–277.
   PubMed Web of Science ®Google Scholar
• Chen SN, Lombardi R, Karmouch J, et al. DNA damage response/TP53 pathway is activated and contributes to the pathogenesis of dilated cardiomyopathy associated with LMNA (Lamin A/C) mutations. Circ Res. 2019;124(6):856–873.
   PubMed Web of Science ®Google Scholar
• Caragnano A, Aleksova A, Bulfoni M, et al. Autophagy and inflammasome activation in dilated cardiomyopathy. J Clin Med. 2019;8(10):45.
   PubMed Web of Science ®Google Scholar
• Zeng C, Duan F, Hu J, et al. NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy. Redox Biol. 2020;34:101523.
   PubMed Web of Science ®Google Scholar
• Li Y, Feng D, Wang Z, et al. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion. Cell Death Differ. 2019;26(11):2284–2299.
   PubMed Web of Science ®Google Scholar
• Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107–125.
   PubMed Web of Science ®Google Scholar
• Wang J, Deng B, Liu Q, et al. Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload. Cell Death Dis. 2020;11(7):574.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ren X, Wang Y, et al. Targeting ferroptosis by polydopamine nanoparticles protects heart against ischemia/reperfusion injury. ACS Appl Mater Interfaces. 2021;13(45):53671–53682.
   PubMed Web of Science ®Google Scholar
• Miyamoto HD, Ikeda M, Ide T, et al. Iron overload via heme degradation in the endoplasmic reticulum triggers ferroptosis in myocardial ischemia-reperfusion injury. JACC Basic Transl Sci. 2022;7(8):800–819.
   PubMedGoogle Scholar
• Wang Z, Xia Q, Su W, et al. Exploring the communal pathogenesis, ferroptosis mechanism, and potential therapeutic targets of dilated cardiomyopathy and hypertrophic cardiomyopathy via a microarray data analysis. Front Cardiovasc Med. 2022;9:824756.
   PubMed Web of Science ®Google Scholar
• Verdonschot JAJ, Merlo M, Dominguez F, et al. Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences. Eur Heart J. 2021;42(2):162–174.
   PubMed Web of Science ®Google Scholar
• Mattson DL. Immune mechanisms of salt-sensitive hypertension and renal end-organ damage. Nat Rev Nephrol. 2019;15(5):290–300.
   PubMed Web of Science ®Google Scholar
• Jia Q, Chu H, Jin Z, Long H, Zhu B. High-throughput single-сell sequencing in cancer research. Signal Transduct Target Ther. 2022;7(1):145.
   PubMed Web of Science ®Google Scholar
• Zhang W, Yao S, Huang H, et al. Molecular subtypes based on ferroptosis-related genes and tumor microenvironment infiltration characterization in lung adenocarcinoma. Oncoimmunology. 2021;10(1):1959977.
   PubMed Web of Science ®Google Scholar
• Li S, Wang Y, Yang W, et al. Cardiac MRI risk stratification for dilated cardiomyopathy with left ventricular ejection fraction of 35% or higher. Radiology. 2022;213059.
   Web of Science ®Google Scholar
• Tang HS, Kwan CT, He J, et al. Prognostic utility of cardiac MRI myocardial strain parameters in patients with ischemic and nonischemic dilated cardiomyopathy: a multicenter study. AJR Am J Roentgenol. 2022:56.
   Google Scholar
• Wu HS, Dong JZ, Du X, et al. Risk factors for left ventricular thrombus formation in patients with dilated cardiomyopathy. Semin Thromb Hemost. 2022:345.
   Web of Science ®Google Scholar
• Wang X, Chen X, Zhou W, et al. Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways. Acta Pharm Sin B. 2022;12(2):708–722.
   PubMed Web of Science ®Google Scholar
• Fang X, Ardehali H, Min J, Wang F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol. 2023;20(1):7–23.
   PubMed Web of Science ®Google Scholar
• Fang X, Wang H, Han D, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A. 2019;116(7):2672–2680.
   PubMed Web of Science ®Google Scholar
• Kwon MY, Park E, Lee SJ, Chung SW. Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death. Oncotarget. 2015;6(27):24393–24403.
   PubMedGoogle Scholar
• Liang L, Sun J, Teng T, et al. Expression profile of inflammation response genes and potential regulatory mechanisms in dilated cardiomyopathy. Oxid Med Cell Longev. 2022;2022:1051652.
   PubMed Web of Science ®Google Scholar
• Pistulli R, König S, Drobnik S, et al. Decrease in dendritic cells in endomyocardial biopsies of human dilated cardiomyopathy. Eur J Heart Fail. 2013;15(9):974–985.
   PubMed Web of Science ®Google Scholar
• Yuan J, Cao AL, Yu M, et al. Th17 cells facilitate the humoral immune response in patients with acute viral myocarditis. J Clin Immunol. 2010;30(2):226–234.
   PubMed Web of Science ®Google Scholar
• Nield LE, von Both I, Popel N, et al. Comparison of immune profiles in fetal hearts with idiopathic dilated cardiomyopathy, maternal autoimmune-associated dilated cardiomyopathy and the normal fetus. Pediatr Cardiol. 2016;37(2):353–363.
   PubMed Web of Science ®Google Scholar
• Lei T, Qian H, Lei P, Hu Y. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma. Cancer Sci. 2021;112(11):4785–4798.
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Jiang X. A physiological function for ferroptosis in tumor suppression by the immune system. Cell Metab. 2019;30(1):14–15.
   PubMed Web of Science ®Google Scholar
• Wang F, Liu Y, Ni F, et al. BNC1 deficiency-triggered ferroptosis through the NF2-YAP pathway induces primary ovarian insufficiency. Nat Commun. 2022;13(1):5871.
   PubMed Web of Science ®Google Scholar
• Wu B, Qiang L, Zhang Y, et al. The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-κB signaling. Cell Mol Immunol. 2022;19(2):276–289.
   PubMed Web of Science ®Google Scholar
• Song J, Liu T, Yin Y, et al. The deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity. EMBO Rep. 2021;22(2):e51162.
   PubMed Web of Science ®Google Scholar
• McClure M, Gopaluni S, Jayne D, Jones R. B cell therapy in ANCA-associated vasculitis: current and emerging treatment options. Nat Rev Rheumatol. 2018;14(10):580–591.
   PubMed Web of Science ®Google Scholar
• Zouggari Y, Ait-Oufella H, Bonnin P, et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med. 2013;19(10):1273–1280.
   PubMed Web of Science ®Google Scholar
• Xu Z, Mei F, Liu H, Sun C, Zheng Z. C-C Motif Chemokine Receptor 9 exacerbates pressure overload-induced cardiac hypertrophy and dysfunction. J Am Heart Assoc. 2016;5(5):453.
   Web of Science ®Google Scholar
• Dahl CP, Husberg C, Gullestad L, et al. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling. Circ Heart Fail. 2009;2(6):624–632.
   PubMed Web of Science ®Google Scholar
• Guo J, Zhang H, Xiao J, et al. Monocyte chemotactic protein-1 promotes the myocardial homing of mesenchymal stem cells in dilated cardiomyopathy. Int J Mol Sci. 2013;14(4):8164–8178.
   PubMed Web of Science ®Google Scholar
• Tay WT, Fang YH, Beh ST, et al. Programmed Cell Death-1: programmed Cell Death-Ligand 1 interaction protects human cardiomyocytes against T-cell mediated inflammation and apoptosis response in vitro. Int J Mol Sci. 2020;21(7):23.
   Web of Science ®Google Scholar